Volume 02 Archives - Page 2 of 2 - Inside Precision Medicine

IPM Magazine

, Volume 02

Website Content from This Issue

News & Features

Pediatric Cancer Genomics Shows Promise in Personalizing Care

October 2, 2015

Source: iStock/Mactrunk

News & Features

Costs of Universal BRCA1/BRCA2 Testing May Exceed Benefits

October 2, 2015

Source: DepositPhotos/Bahrialtay

New Liquid Biopsy Detects Cancer-Associated Mutations in High-Risk Patients

October 2, 2015

New test detects DNA fragments that are shed from cancer cells and released into the bloodstream. [iStock/ElementalImaging]

News & Features

Case Study: Enabling a Paradigm Shift in Precision Medicine

October 1, 2015

The Parsortix CTC isolation system.

The Pons Asinorum of Diagnostic Genomics

October 1, 2015

Source: Wikicommons/Oliver Byrne’s Elements of Euclid

Drawing Battle Lines over Lab Tests

October 1, 2015

The FDA wants to assign LDTs a risk classification of low

Pure Innovation Drives Clinical-Grade NGS

October 1, 2015

The Genome in a Bottle Consortium has developed the world’s first well-characterized whole human genome reference material. [Genome in a Bottle Consortium]

News & Features

The Great Cancer Prognosticator

October 1, 2015

Beating cancer depends on early detection. Predictive diagnosis could improve survival rates dramatically. [iStock/Wildpixel]

Generating Robust NGS Data for Personalized Medicine

January 6, 2015

Figure 1. On-Bead Post-Capture PCR Amplification Enhances Enrichment. Target capture was performed using xGen® Lockdown® Probes and SeqCap® EZ Hybridization and Wash Kit. Relative levels of three target genes after enrichment were measured by qPCR.

Reimbursing NGS Testing

January 6, 2015

The rapid development of NGS-based tests for use in oncology has highlighted this technology’s tremendous potential to improve clinical care and patient outcomes.

Opinions Divided on Proposed FDA LDT Regulations

January 6, 2015

FDA has concerns over the adequacy of the scientific evidence supporting the use of many laboratory developed tests. [Kasto/Fotolia]

News & Features

Biomarkers and Cancer: Correlation Is Not Causation

January 6, 2015

Source: Nelsonart/Deposit Photos

A Crowded Field for Noninvasive Prenatal Screening Tests

January 6, 2015

The prenatal diagnostics industry is expected to reach $3.6 billion by 2019 with the demand for prenatal tests tripling over the next six years. [Mopic/Fotolia]